Sec. 5. Negotiation of lower covered part D drug prices on behalf of medicare beneficiaries

292 words·~1 min read·/bill/116/hr/1346/ih/section-5

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 1860D–11 of the Social Security Act ( 42 U.S.C. 1395w–111 ) is amended by striking subsection

(i)(relating to noninterference) and inserting the following: Notwithstanding any other provision of law, the Secretary shall negotiate with pharmaceutical manufacturers the prices (including discounts, rebates, and other price concessions) that may be charged to PDP sponsors and MA organizations for covered part D drugs for part D eligible individuals who are enrolled under a prescription drug plan or under an MA–PD plan. Nothing in paragraph

(1)shall be construed to authorize the Secretary to establish or require a particular formulary. Subparagraph

(A)shall not be construed as affecting the Secretary's authority to ensure appropriate and adequate access to covered part D drugs under prescription drug plans and under MA–PD plans, including compliance of such plans with formulary requirements under section 1860D–4(b)(3). Nothing in this subsection shall be construed as preventing the sponsor of a prescription drug plan, or an organization offering an MA–PD plan, from obtaining a discount or reduction of the price for a covered part D drug below the price negotiated under paragraph (1). Not later than June 1, 2022, and every 6 months thereafter, the Secretary shall submit to the Committees on Ways and Means, Energy and Commerce, and Oversight and Reform of the House of Representatives and the Committee on Finance of the Senate a report on negotiations conducted by the Secretary to achieve lower prices for Medicare beneficiaries, and the prices and price discounts achieved by the Secretary as a result of such negotiations. . The amendment made by subsection

(a)shall take effect on the date of the enactment of this Act and shall first apply to negotiations and prices for plan years beginning on January 1, 2022.

Connections1 off-index

1 reference not yet in our index

42 USC 1395w–111

Citation graph

cites case law

Sec. 5

Negotiation of lower covered part D drug prices on behalf of medicare beneficiaries

Cite42 USC 1395w–111

Cites 1Cited by 0 across 0 sources